Oncology News

The award was presented by journalist and cancer advocate Bayer has a long-standing commitment to Cancer Care's mission of providing free support services to individuals affected by a cancer diagnosis.

That's the strategy the drug industry is following in a wave of deals where small companies are getting bigger and the big ones are getting smaller.

The HuPrime model collection, many of which are maintained 'in life', enable drug discovery companies to run Clinical Trial-like studies, or HuTrialTM, using human surrogate models in mice.

Four innovators from oncology practices across the country described how payment reform is shaping the way they treat cancer.

The ASCO Annual Meeting is the premier annual oncology symposium, bringing together more than 25,000 oncology professionals from a broad range of specialties.

Sitting just two miles apart on opposite banks of the Rhine river in Basel, Switzerland, Novartis AG and Roche Holding AG have long had a complex crosstown rivalry.

For nine years, Donna Claire Newman and her red four-door Toyota Matrix have been ferrying cancer patients to their doctor and therapy appointments around Memphis.

The US Food and Drug Administration has suggested that surgeons refrain from using tissue-grinding tools to remove uteruses or uterine growths because they increase the risk of spreading undetected cancer.

A new drug for breast cancer which extends women's lives by almost six months is to be blocked from routine NHS access under draft guidance issued by a health watchdog.

An Omaha man is dealing with a very rare form of cancer that only two out of a million people get diagnosed with each year, but he's not alone.

Cambridge, UK, 22nd April 2014: Sentinel Oncology Ltd. , the small molecule drug discovery company, today announced it has signed a collaboration agreement with Oncothyreon Inc. for development of Sentinel's Checkpoint Kinase 1 programme.

When a particularly effective medical treatment also turns out to be particularly expensive, it creates a quandary for the insurers and patients who foot the bill.

Today's headlines are full of alarm bells about the American health care system.

Novartis and GlaxoSmithKline traded over $20 billion worth of assets on Tuesday, aiming to bolster their best businesses and exit weaker ones as the drugs industry reshapes to cope with healthcare spending cuts and generic competition.

For your information: MNT accounts were not affected by the recent Heartbleed bug, as we were not running a vulnerable version of OpenSSL.

British drug giant GlaxoSmithKline announced Tuesday that it will sell its cancer-products business to pharmaceutical giant Novartis, in a deal that will see the firm's Swiss rival pay $14.5 billion for its oncology unit.

Amy is a Chinese American journalist - a native New Yorker - and journalism educator currently living in Hong Kong.

The US Food and Drug Administration today announced that is has approved Cyramza for the treatment of patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach.

An Omaha man is dealing with a very rare form of cancer that only two out of a million people get diagnosed with each year, but he's not alone.

Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers' award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and ... (more)